Guidelines

  1. “EANM Guideline on Quality Risk Management for Radiopharmaceuticals” N. Gillings, O. Hjelstuen, M. Behe, C. Decristoforo, P. H. Elsinga, V. Ferrari, O. C. Kiss, P. Kolenc, J. Koziorowski, P. Laverman, T. L. Mindt, M. Ocak, M. Patt, S. Todde, A. Walte European Journal of Nuclear Medicine and Molecular Imaging 2022, on-line. DOI: https://doi.org/10.1007/s00259-022-05738-4
  2. “Guideline on Current Good Radiopharmacy Practice (cGRPP) for the Small-Scale Preparation of Radiopharmaceuticals – Revision 2019” N. Gillings, S. Todde, M. Behe, C. Decristoforo, P. Elsinga, V. Ferrari, O. Hjelstuen, P. Kolenc-Peitl, J. Koziorowski, P. Laverman, T. L. Mindt, E. Ocak, M. Patt European Journal of Nuclear Medicine and Molecular Imaging – Radiopharmacy and Chemistry 2021, 6:8. DOI: 10.1186/s41181-021-00123-2
  3. “EANM Guideline on the Validation of Analytical Methods for Radiopharmaceuticals” N. Gillings, S. Todde, M. Behe, C. Decristoforo, P. Elsinga, V. Ferrari, O. Hjelstuen, P. Kolenc-Peitl, J. Koziorowski, P. Laverman, T. L. Mindt, E. Ocak, M. Patt European Journal of Nuclear Medicine and Molecular Imaging – Radiopharmacy and Chemistry 2020, 5 (1), 7. DOI: 10.1186/s41181-019-0086-z
  4. “Status of the «Consensus Nomenclature Rules in Radiopharmaceutical Sciences» Initiative” H. H. Coenen, A. D. Geeb, M. Adam, G. Antoni, C. S. Cutler, Y. Fujibayashi, J. M. Jeong, R. H. Mach, T. L. Mindt, V. W. Pike, A., D. Windhorst Nuclear Medicine and Biology 2019, 71, 19-22. DOI: j.nucmedbio.2019.05.001
  5. “Consensus Nomenclature Rules for Radiopharmaceutical Chemistry – Setting the Record Straight“ M. Adam, G. Antoni, H. H. Coenen, C. S. Cutler, Y. Fujibayashi, A. D. Gee, J. M. Jeong, R. H. Mach, T. L. Mindt, V. W. Pike, A. Windhorst Nuclear Medicine and Biology 2017, 55, v-xi. DOI: 10.1016/j.nucmedbio.2017.09.004
  6. “Guidance on Validation and Qualification of Processes and Operations Involving Radiopharmaceuticals” S. Todde, P. Kolenc Peitl, P. H. Elsinga, J. Koziorowski, V. Ferrari, M. Ocak, O. Hjelstuen, M. Patt, T. L. Mindt, M. Behe European Journal of Nuclear Medicine and Molecular imaging – Radiopharmacy and Chemistry 2017, 2, 8. DOI: 10.1186/s41181-017-0025-9
  7. “Position Paper on Requirements for Toxicological Studies in the Specific Case of Radiopharmaceuticals” J. Koziorowski, M. Behe, C. Decristoforo, J. Ballinger, P. Elsinga, V. Ferrari, P. Kolenc Peitl, S. Todde, T. L. Mindt European Journal of Nuclear Medicine and Molecular Imaging – Radiopharmacy and Chemistry 2016, 1, 1-6. DOI: 10.1186/s41181-016-0004-6
  8. “Guidance on Current Good Radiopharmacy Practice for the Small-Scale Preparation Radiopharmaceuticals Using  Automated Modules: a European Perspective” J. Aerts, J. R. Ballinger, M. Behe, C. Decristoforo, P. H. Elsinga, A. Faivre-Chauvet, T. L. Mindt, P. Kolenc Peitl, S. C. Todde, J. Koziorowski. Journal of Labeled Compounds and Radiopharmaceuticals 2014, 57, 615-620. DOI: 10.1002/jlcr.3227
  9. “EANM Guideline for the Preparation of an Investigational Medicinal Product Dossier (IMPD)” S. Todde, A. D. Windhorst, M. Behe, G. Bormans, C. Decristoforo, A. Faivre-Chauvet, V. Ferrari, A, D. Gee, B. Gulyas, C. Halldin, P. Kolenc-Peitl, J. Koziorowski, T. L. Mindt, M. Sollini, J. Vercouillie, J. R. Ballinger, P. H. Elsinga European Journal of Nuclear Medicine and Molecular Imaging2014, 41, 2175-2185. DOI: 10.1007/s00259-014-2866-8